Literature DB >> 15812564

Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval.

Adi Levi1, Yoav Kohn, Kyra Kanyas, Daniela Amann, Chi-Un Pae, Adnan Hamdan, Ronnen H Segman, Nili Avidan, Osnat Karni, Mira Korner, Tae-Yun Jun, Jacques S Beckmann, Fabio Macciardi, Bernard Lerer.   

Abstract

We previously reported an autosomal scan for schizophrenia susceptibility loci in a systematically recruited sample of Arab Israeli families. The scan detected significant evidence for linkage at chromosome 6q23 with a nonparametric LOD score (NPL) of 4.60 (P=0.000004) and a multipoint parametric LOD score of 4.16. In order to refine this finding we typed 42 additional microsatellite markers on chromosome 6q between D6S1570 (99.01 cM from the pter) and D6S281 (190.14 from the pter) in the same sample (average intermarker distance approximately 1.7 cM). In the 23 cM region between D6S1715 and D6S311, markers were more closely spaced ( approximately 1.1 cM). Multipoint nonparametric and parametric and single point linkage analyses were performed. The peak NPL rose to 4.98 (P=0.00000058) at D6S1626 (136.97 cM), immediately adjacent to D6S292 (NPL 4.98, P=0.00000068), the marker that gave the highest NPL in the original genome scan, under the broad diagnostic category. The putative susceptibility region (NPL-1) was reduced from 12.0 to 4.96 cM. The peak multipoint parametric LOD score was 4.63 at D6S1626 under a dominant genetic model, core diagnostic category and the LOD-1 interval was 2.10 cM. The maximum single point LOD score (3.55, theta=0.01) was also at D6S1626 (dominant model, core diagnostic category). Increased evidence for linkage in the same sample as in the original genome scan and consistent localization of the linkage peak add further support for the presence of a schizophrenia susceptibility locus at chromosome 6q23. Moreover, the markedly reduced linkage interval greatly improves prospects for identifying a schizophrenia susceptibility gene within the implicated region.

Entities:  

Mesh:

Year:  2005        PMID: 15812564     DOI: 10.1038/sj.ejhg.5201406

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia.

Authors:  Jibin John; Prachi Kukshal; Triptish Bhatia; K V Chowdari; V L Nimgaonkar; S N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2017-02-24       Impact factor: 4.939

Review 2.  Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.

Authors:  C J Hillard; K M Weinlander; K L Stuhr
Journal:  Neuroscience       Date:  2011-11-17       Impact factor: 3.590

3.  Neuronal Abelson helper integration site-1 (Ahi1) deficiency in mice alters TrkB signaling with a depressive phenotype.

Authors:  Xingshun Xu; Hao Yang; Yung-Feng Lin; Xiang Li; Austin Cape; Kerry J Ressler; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

4.  A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia.

Authors:  Andrés Ingason; Ina Giegling; Sven Cichon; Thomas Hansen; Henrik B Rasmussen; Jimmi Nielsen; Gesche Jürgens; Pierandrea Muglia; Annette M Hartmann; Eric Strengman; Catalina Vasilescu; Thomas W Mühleisen; Srdjan Djurovic; Ingrid Melle; Bernard Lerer; Hans-Jürgen Möller; Clyde Francks; Olli P H Pietiläinen; Jouko Lonnqvist; Jaana Suvisaari; Annamari Tuulio-Henriksson; Muriel Walshe; Evangelos Vassos; Marta Di Forti; Robin Murray; Chiara Bonetto; Sarah Tosato; Rita M Cantor; Marcella Rietschel; Nick Craddock; Michael J Owen; Leena Peltonen; Ole A Andreassen; Markus M Nöthen; David St Clair; Roel A Ophoff; Michael C O'Donovan; David A Collier; Thomas Werge; Dan Rujescu
Journal:  Hum Mol Genet       Date:  2010-01-12       Impact factor: 6.150

5.  Association of common variants in the Joubert syndrome gene (AHI1) with autism.

Authors:  Ana I Alvarez Retuerto; Rita M Cantor; Joseph G Gleeson; Anna Ustaszewska; Wendy S Schackwitz; Len A Pennacchio; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2008-09-09       Impact factor: 6.150

6.  Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.

Authors:  Zhihua Xie; Eric J Vallender; Naichen Yu; Shelli L Kirstein; Hong Yang; Mary E Bahn; Susan V Westmoreland; Gregory M Miller
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

Review 7.  International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature.

Authors:  Janet J Maguire; William A E Parker; Steven M Foord; Tom I Bonner; Richard R Neubig; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

8.  Polymorphisms in AHI1 are not associated with type 2 diabetes or related phenotypes in Danes: non-replication of a genome-wide association result.

Authors:  J Holmkvist; S Anthonsen; L Wegner; G Andersen; T Jørgensen; K Borch-Johnsen; A Sandbaek; T Lauritzen; O Pedersen; T Hansen
Journal:  Diabetologia       Date:  2008-01-29       Impact factor: 10.122

9.  Genetic liability to schizophrenia in Oceanic Palau: a search in the affected and maternal generation.

Authors:  Bernie Devlin; Lambertus Klei; Marina Myles-Worsley; Josepha Tiobech; Caleb Otto; William Byerley; Kathryn Roeder
Journal:  Hum Genet       Date:  2007-04-14       Impact factor: 5.881

10.  Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study.

Authors:  Olga Rivero; Andreas Reif; Julio Sanjuán; María D Moltó; Sarah Kittel-Schneider; Carmen Nájera; Theresia Töpner; Klaus-Peter Lesch
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.